Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Syphilis: early-phase trial registry

3 of 7 indexed Syphilis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Syphilis: 7 US clinical trials tracked, 3 recruiting.

Syphilis is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Southern California, running 2 of these trials.

Enrollment posture brief

Registry condition syphilis

OPEN 3 | RECR 43% | LATE 1 | EARLY 2 | RANK #2497 | SPON 2

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Syphilis (this)43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Syphilis

Syphilis lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Syphilis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Syphilis is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Syphilis research.

    University of Southern California accounts for 2 of 7 trials (28.6%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Syphilis enrolment sits around 75 participants.

    Median target enrolment is 75 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.

  4. Syphilis research is mostly interventional.

    7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 31

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 1

Named interventions

Most-linked intervention names on Syphilis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

mLab App Plus Behavioral
1 trials
Motivational interviewing and specimen self-collection Behavioral
1 trials
Group A, Penicillin Drug
1 trials
Group B, Linezolid 10d Drug
1 trials
Center for Disease Control (CDC) Sexually Transmitted Infections (STI) 2021 Treatment Guidelines for diagnosis of syphilis Other
1 trials
Aptima Treponema pallidum transcription-mediated amplification (TMA) assay for detection of Treponema pallidum Diagnostic test
1 trials
Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum Diagnostic test
1 trials
Doxycycline 200mg daily for 14 days Drug
1 trials

US sites by state

Facility locations filed on Syphilis trials. A trial with sites in several states counts in each.

New York 2 trials
California 2 trials
Washington 1 trials
Texas 1 trials
Tennessee 1 trials
Rhode Island 1 trials
Ohio 1 trials
North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Syphilis page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Syphilis condition card totals 7 registered trials; most-linked intervention mLab App Plus; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.